ConductScience.org, home

Paper2011397

Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas.

Varley JM and 5 others. Oncogene, 1991. Cited by 262 papers, by iCite.

Cite this record

ConductScience Library. Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas. Papers, record 2011397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2011397

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas.
PubMed
Journal
Oncogene
PubMed
Year
1991
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
262
iCite
Relative citation ratio, by iCite
6.7
iCite
Revised in PubMed
2006-11-15
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Varley JMJ M
2Brammar WJW J
3Lane DPD P
4Swallow JEJ E
5Dolan CC
6Walker RAR A

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Chromosomes, Human, Pair 17Major topic
MutationMajor topic
Tumor Suppressor Protein p53Major topic
Alleles
Amino Acid Sequence
Base Sequence
Electrophoresis, Agar Gel
Gene Expression Regulation, Neoplastic
Humans
Immunohistochemistry
Molecular Sequence Data
Nucleic Acid Hybridization
Polymerase Chain Reaction

Source PubMed

Download CSV of topics

Cited by55

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 262 citations.

PMIDTitleJournalYearIn PapersSource
40694182Efficacy analysis of targeted P53 therapy in solid tumors.Med Oncol2025https://conductscience.org/library/papers/40694182PubMed
32873579p53 tetramerization: at the center of the dominant-negative effect of mutant p53.Genes Dev2020https://conductscience.org/library/papers/32873579PubMed
26626427Positive expression of NANOG, mutant p53, and CD44 is directly associated with clinicopathological features and poor prognosis of oral squamous cell carcinoma.BMC Oral Health2015https://conductscience.org/library/papers/26626427PubMed
24667108Amplification of Mdmx and overexpression of MDM2 contribute to mammary carcinogenesis by substituting for p53 mutations.Diagn Pathol2014https://conductscience.org/library/papers/24667108PubMed
23404560P53 immunohistochemical expression does not correlate with clinical features in 207 carcinomas of the oral cavity and in the head and neck region.Clin Oral Investig2014https://conductscience.org/library/papers/23404560PubMed
23105839Study of mutations in p53 tumour suppressor gene in human sporadic breast cancers.Indian J Clin Biochem2009https://conductscience.org/library/papers/23105839PubMed
21793850Assessing estrogen signaling aberrations in breast cancer risk using genetically engineered mouse models.Ann N Y Acad Sci2011https://conductscience.org/library/papers/21793850PubMed
20606732CD44 and p53 immunoexpression patterns in NF1 neoplasms - indicators of malignancy and infiltration.Int J Clin Exp Pathol2010https://conductscience.org/library/papers/20606732PubMed
20466998Deregulated estrogen receptor alpha and p53 heterozygosity collaborate in the development of mammary hyperplasia.Cancer Res2010https://conductscience.org/library/papers/20466998PubMed
20042682Influence of Hoxa5 on p53 tumorigenic outcome in mice.Am J Pathol2010https://conductscience.org/library/papers/20042682PubMed
19261255Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic response.Lancet Oncol2009https://conductscience.org/library/papers/19261255PubMed
18528466The individualization of cancer therapy: the unexpected role of p53.Trans Am Clin Climatol Assoc2006https://conductscience.org/library/papers/18528466PubMed
16753067Inter-relationship between microsatellite instability, thymidylate synthase expression, and p53 status in colorectal cancer: implications for chemoresistance.BMC Cancer2006https://conductscience.org/library/papers/16753067PubMed
16696013Biological indices in the assessment of breast cancer.Clin Mol Pathol1995https://conductscience.org/library/papers/16696013PubMed
16695986p53 overexpression in Ewing's sarcoma/primitive neuroectodermal tumour is an uncommon event.Clin Mol Pathol1995https://conductscience.org/library/papers/16695986PubMed
15864644The efficacy of trastuzumab in Her-2/neu-overexpressing metastatic breast cancer is independent of p53 status.J Cancer Res Clin Oncol2005https://conductscience.org/library/papers/15864644PubMed
11440404Prognostic implications of p53 and bcl-2 expression in 108 women with stage two breast cancer.Ir J Med Sci2001https://conductscience.org/library/papers/11440404PubMed
11040937Molecular pathogenesis of oral squamous carcinoma.Mol Pathol2000https://conductscience.org/library/papers/11040937PubMed
9514060Allelic imbalance at chromosome 17p13.3 (YNZ22) in breast cancer is independent of p53 mutation or p53 overexpression and is associated with poor prognosis at medium-term follow-up.Br J Cancer1998https://conductscience.org/library/papers/9514060PubMed
9512119Expression of p53 and p21WAF1/CIP1 proteins in gastric and esophageal cancers: comparison with mutations of the p53 gene.Dig Dis Sci1998https://conductscience.org/library/papers/9512119PubMed

See all 55 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2011397

GET https://conductscience.org/api/papers/v1/2011397/cited_by?page=2